Improving the safety of newly approved drugs

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1337, 2002-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new look at safety for newly approved drugs

By  

Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

A new look at safety for newly approved drugs

By  

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Metabolic and toxicological considerations of newly approved prostate cancer drugs

By Tsao Che-Kai   Liaw Bobby   Yee Tiffany   Galsky Matthew D   Oh William K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 835-846

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of immunosuppressive drugs approved in EU through the centralised procedure

By Bertele’ Vittorio   Buonocore Carmela   Michelacci Francesca   Vitocolonna Maria   Garattini Silvio  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 7, 2007-07 ,pp. : 707-712

Springer Publishing Company

Access to resources Recommend Favorite

Public misconceptions about FDA-approved drugs

By  

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite